Update on synovitis
- 1 February 2001
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 3 (1) , 53-63
- https://doi.org/10.1007/s11926-001-0051-0
Abstract
Rheumatoid arthritis (RA) is an inflammatory disorder associated with chronic synovitis, eventually leading to cartilage and bone destruction in the joints. Synovitis is associated with the activation of various cells in the synovium including synovial lining cells, interstitial macrophages, endothelial cells, lymphocytes, and fibroblasts. The key mechanisms underlying synovitis include inflammatory cell adhesion and activation, the production of mediators (such as cytokines, chemokines, and growth factors), angiogenesis, joint destruction, fibrosis, and bone resorption. These important events, as well as the role of inflammatory cells, cell surface molecules, and soluble mediators are updated and discussed in this review. Some aspects and strategies of current or future immunotherapy are also discussed because these animal and human trials provide information on the pathogenesis of inflammatory synovitis.Keywords
This publication has 55 references indexed in Scilit:
- Lyn and Syk tyrosine kinases are not activated in B‐lineage lymphoid cells exposed to low‐energy electromagnetic fieldsThe FASEB Journal, 2000
- A proinflammatory role for IL-18 in rheumatoid arthritisJournal of Clinical Investigation, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model.Journal of Clinical Investigation, 1998
- The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.Journal of Clinical Investigation, 1998
- Cytokines in Rheumatoid ArthritisDrugs & Aging, 1998
- Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1Nature, 1995
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityPublished by Elsevier ,1991